Changes to Hepatitis C Treatment
February 1, 2019
Hepatitis C Treatment - Update to pathway and claiming process
The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™.
Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis:
Cure rate of 99%...
TAGS
abscesscellulitisdvtECGCOVID19OSTRivaroxabanTroponinACSAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScephazolinChest PainclexaneCOVIDCXRcystdehydrationdentalectopicFAQsFerinjectgynaeHep CHepatitisINRIVIV ironmaternityMaviretNurse Advisorovarianovarian cystovarian torsionpaediatric cellulitispelvic painpelvic scanpelvic ussPIDPOACPOAC ECGpoac pelvic\Sarah Hydersore throattonsilitistoothachewells scoreX ray and COVID swabXray